iRhythm CFO sells shares for RSU tax withholding

iRhythm Holdings, Inc. Chief Financial Officer Daniel G. Wilson reported open-market sales of company common stock primarily for tax withholding.

Rhea-AI Filing Summary

iRhythm Holdings, Inc. Chief Financial Officer Daniel G. Wilson reported open-market sales of company common stock primarily for tax withholding. On March 2, 2026, he sold a total of 3,395 shares of common stock in several open-market transactions at prices around $128.44 per share to cover tax withholding and remittance obligations related to vesting Restricted Stock Units.

After these sales, Wilson directly owned 35,660 shares of iRhythm common stock and indirectly held 100 shares through The Wilson Living Trust dated July 9, 2015, of which he is the trustee.

Insider Trade Summary

Net Seller: 3,395 shares

Net Sell 5 txns

Insider Wilson Daniel G.

Role Chief Financial Officer

Sold 3,395 shs ($436K)

Type	Security	Shares	Price	Value
Sale	Common Stock	755	$128.4387	$97K
Sale	Common Stock	815	$128.4411	$105K
Sale	Common Stock	564	$128.4523	$72K
Sale	Common Stock	1,261	$128.4525	$162K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 35,660 shares (Direct); Common Stock — 100 shares (Indirect, Held through a Family Trust)

Footnotes (2)

1. F1. These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).
2. F2. These shares represent an indirect ownership through The Wilson Living Trust dated July 9, 2015, of which Mr. Wilson is the Trustee.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did iRhythm (IRTC) CFO Daniel G. Wilson report in this Form 4?

iRhythm (IRTC) CFO Daniel G. Wilson reported multiple open-market sales of common stock. The transactions on March 2, 2026 totaled 3,395 shares, sold mainly to cover tax withholding obligations tied to vesting Restricted Stock Units, according to the disclosed footnote.

How many iRhythm (IRTC) shares did the CFO sell and at what prices?

The CFO sold 3,395 shares of iRhythm common stock in several trades. Transaction prices were approximately $128.44 per share, with reported individual prices of $128.4387, $128.4411, $128.4523, and $128.4525 on March 2, 2026.

Why did the iRhythm (IRTC) CFO sell shares according to the Form 4?

The Form 4 states the shares were sold to cover tax withholding and remittance obligations. These obligations arose from the vesting of Restricted Stock Units, meaning the sales were tied to equity compensation taxation rather than standalone discretionary selling activity.

How many iRhythm (IRTC) shares does the CFO hold after these transactions?

After the reported transactions, the CFO directly owned 35,660 shares of iRhythm common stock. He also indirectly held 100 shares through The Wilson Living Trust dated July 9, 2015, where he serves as trustee, reflecting both direct and trust-based ownership.

What indirect iRhythm (IRTC) share ownership did the Form 4 disclose for the CFO?

The filing shows 100 iRhythm common shares held indirectly through The Wilson Living Trust dated July 9, 2015. The footnote explains that Daniel G. Wilson is the trustee of this trust, which clarifies how these indirectly owned shares are controlled.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 06:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilson Daniel G.

(Last) (First) (Middle)

C/O IRHYTHM HOLDINGS, INC.

699 8TH ST #600

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026	03/02/2026	S		755(1)	D	$128.4387	38,300	D
Common Stock	03/02/2026	03/02/2026	S		815(1)	D	$128.4411	37,485	D
Common Stock	03/02/2026	03/02/2026	S		564(1)	D	$128.4523	36,921	D
Common Stock	03/02/2026	03/02/2026	S		1,261(1)	D	$128.4525	35,660	D
Common Stock								100(2)	I	Held through a Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

2. These shares represent an indirect ownership through The Wilson Living Trust dated July 9, 2015, of which Mr. Wilson is the Trustee.

Remarks:

	/s/ Marc Rosenbaum, attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.